T1	Participants 210 253	patients with manic and mixed mood episodes
T2	Participants 486 602	patients presenting with a mixed index episode who were enrolled in a larger double-blind, placebo-controlled trial.
T3	Participants 603 725	Patients who met remission criteria at 2 consecutive weekly visits during 6 to 12 weeks of open-label olanzapine treatment
T4	Participants 975 987	304 patients
